PLX PHARMA INC Revenue, Profits - PLXP Annual Income Statement

Add to My Stocks
$4.23 $0.12 (2.76%) PLXP stock closing price Sep 19, 2018 (Closing)

Financial analysis of PLX PHARMA INC involves more than just checking the PLX PHARMA INC stock price, by looking at the financial statements of the company in detail. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the PLXP stock. One also needs to look at PLX PHARMA INC assets, operating expenses and PLX PHARMA INC free cash flow. The PLX PHARMA INC profit and loss statement shows revenue of $- for 2017. Revenue has decreased by 0 YOY for PLXP stock.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
PLX PHARMA INC Revenues or Net Sales
Cost Of Goods Sold (COGS)------
Research & Development Expense4.15M12.75M11.28M8.89M1.72M-
Selling General & Admin Expense12.46M8.61M7.47M4.68M2.28M-
Income Before Depreciation Depletion Amortization-15.84M-21.36M-18.76M-13.58M-4.01M-1.84M
Depreciation Depletion Amortization------
Non Operating Income------
Interest Expense1.16M-----
PLX PHARMA INC Pretax Income
Provision for Income Taxes-0.92M-----
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations-15.34M-21.32M-18.74M-13.58M-4.01M-1.84M
Extraordinary Items & Discontinued Operations------
PLX PHARMA INC Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS7.02M-1.18M---
Average Shares used to compute Basic EPS7.02M-1.18M---
Income Before Nonrecurring Items-13.69M--18.74M-13.58M-4.01M-1.84M
Income from Nonrecurring Items-1.66M-----
PLX PHARMA INC Earnings Per Share Basic Net
PLX PHARMA INC Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-1.95--15.92-13.84-6.96-3.60
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Achaogen financial analysis

PLX PHARMA INC stock analysis involves checking at least a few of the important things like:

  • Topline: A growing topline, as seen from the PLX PHARMA INC revenue chart, as isn't the case with PLX PHARMA INC indicates a sagging business. One needs to compare the YoY topline or sales growth of PLXP stock with its peers like ONTX stock and TRLPF stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-15.34M for PLX PHARMA INC for 2017. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the PLXP income statement, one can check the PLX PHARMA INC historical stock prices to check how the price has moved with time.

PLX PHARMA INC Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield